Browse studies

Find your next paid study

1 recruiting study matching your filters

ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

The purpose of this study is to evaluate the safety and efficacy of pumitamig in combination with chemotherapy versus bevacizumab in combination with chemother…

Untreated, Unresectable, or Metastatic Colorectal Cancer

Bristol-Myers SquibbNCT07221357